semaglutide and muscle wasting See how paired with nutrition weight training can help you achieve your wellness goals A patient on semaglutide loses

retatrutide achieved 24.2% at 48 weeks in Phase 2 (12mg) and 28.7% at 68 weeks in Phase 3 (12mg, OA population)

Tirzepatide: dual GIP/GLP-1 receptor agonism Tirzepatide demonstrated that dual incretin receptor agonism could produce greater weight loss than earlier single-receptor approaches

Potential Side Effects Both medications can cause similar side effects, primarily gastrointestinal issues such as nausea, vomiting, diarrhea, and constipation

By enhancing the effects of GLP-1, Ozempic use helps you eat less, manage your weight more effectively, and better control blood sugar levels - making it particularly beneficial for individuals with diabetes

15271534, Dec